MXCT Stock Price
MaxCyte, Inc.
MXCT stock price is $1.25 (+29.63% on the day), giving MaxCyte, Inc. a market cap of $99.52M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
MXCT Stock Overview
- Price
- $1.25
- Previous close
- $0.96
- Open
- $1.23
- Market cap
- $99.52M
- P/E ratio
- -2.2
- 52-week range
- $0.64 - $1.86
- 1-year price target
- $4.67
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NGS
- MarketXLS Rank
- 30
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MXCT | $1.25 | +29.6% | 12.60M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |